TruSpine Technologies plc (TSP) ORD GBP0.0001
No change
- Add to watchlist
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Business summary
TruSpine Technologies Plc is a United Kingdom-based medical device company focused on the spinal (vertebral) stabilization market. The Company's flagship spinal fixation devices include Cervi-LOK, GRASP Laminoplasty system and Faci-LOK. Cervi-LOK is a screw free spinal stabilization system, used in the cervical spine that minimizes risk of vertebral artery injury which can cause brainstem stroke or nerve root and spinal cord injury. GRASP Laminoplasty system is used in the treatment of decompression of the spinal cord. GRASP Laminoplasty system is both minimally invasive in application, and does not require the use of any screws, thereby avoiding damage to the bony anatomy with respect to its fixation and anchoring. Faci-LOK system takes advantage of anatomic features on the posterior aspect of the lumbar and lower thoracic vertebra that predispose themselves to the application of grasping anchors. Faci-LOK Anchor is formed by an upper (cranial) element and a lower (caudal) element.
Contact details
Important dates
General stock information
- EPIC:
- TSP
- ISIN:
- GB00BMZCKL55
- Market cap:
- £841,650
- Shares in issue:
- 139.69 million
- Sector:
- No specific industry
- Exchange:
- -
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.